EMEA-002886-PIP01-20

Table of contents

Key facts

Active substance
Human, recombinant, non-fucosylated IgG1k monoclonal antibody targeting OX-40 receptor on activated T cells (KHK4083)
Therapeutic area
Dermatology
Decision number
P/0320/2021
PIP number
EMEA-002886-PIP01-20
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of atopic dermatitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Kyowa Kirin Pharmaceutical Development Limited

Tel. +44 1896664000
E-mail: medinfo@kyowakirin.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating